A new in-home device that monitors movement and gait speed can evaluate Parkinson's disease severity, progression, and a patient's response to medication.
Researchers successfully turned skin cells from Parkinson's patients into dopaminergic neurons by introducing a combination of neural-inducing genes into the skin cells.
COVID-19 infection has been linked to a range of lasting neurological and psychological disorders, including depression, memory problems, and Parkinson's-like disorders, within the first year following infection.
Early-to-midlife infections that require hospital care are associated with an increased risk of developing Alzheimer's and Parkinson's disease later in life, a new study reports.
Irisin, a hormone secreted into the blood during high endurance and aerobic exercise, reduces levels of alpha-synuclein and restores movement in mouse models of Parkinson's disease.
Study reveals a novel mechanism in locus coeruleus neurons caused by the loss of the GPT2 mitochondrial enzyme that is implicated in the development and progression of neurodegenerative diseases.
A newly developed artificial intelligence model can detect Parkinson's disease by reading a person's breathing patterns. The algorithm can also discern the severity of Parkinson's disease and track progression over time.
Those with hereditary hemochromatosis who have two copies of the gene mutation that cause the disorder have an increased risk of developing movement disorders including Parkinson's disease.
Cellular changes associated with Parkinson's disease could be revealed with the use of quantitative MRI which allows for a deeper examination of microstructures within the striatum.
Consuming seven or more units of alcohol per week is associated with increased iron levels in the brain. Higher levels of iron in the brain is linked to increased risk of neurodegenerative disorders and alcohol-related cognitive decline.